2018 digital review: AI on the rise in pharma - Pharmaphorum

Digital technology is playing an increasingly important role in healthcare, and in the pharma industry as it searches for ways to find new drugs, while cutting costs and reducing expensive trial failures. The UK government's life sciences tsar, Sir John Bell, set the tone for 2018, when he went on record to say that artificial intelligence (AI) could save billions of pounds for the NHS. Bell told the BBC that researchers at an Oxford hospital have AI technology for diagnosing heart disease that could shave £2.2 billion from the NHS' pathology spend. Another AI system developed by a company called Optellum could allow more than 4,000 cancer patients a year to be diagnosed earlier. This could save £10 billion if adopted in the US and EU, according to the company's science and technology officer, Dr Timor Kadir.